For example, Tian et al. have reported lncRNA AGAP2-AS1 is significantly upregulated in GBM and high expression levels of AGAP2-AS1 predicts is a marker of poor prognosis for GBM patients21. This evidence concerns the gene AGAP2 and glioblastoma.